VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 5219 · 114th Congress

Safe Medications for Moms and Babies Act of 2016

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

JHR Herrera BeutlerSponsor
11 cosponsors · 9 D, 2 R
KCD Castor RCR Costello GND Napolitano LCD Capps LRD Roybal-Allard DWD Wasserman Schultz JKR Katko DCD Cicilline CPD Pingree EED Engel JCD Cooper

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill requires the Department of Health and Human Services to establish the Task Force on Research Specific to Pregnant Women and Lactating Women to report on issues including: (1) the development of safe and effective therapies for such women, (2) ethical issues surrounding the inclusion of such women in clinical research, and (3) federal research…

What it does: CRS summary · Introduced in House · May 12, 2016

Safe Medications for Moms and Babies Act of 2016

This bill requires the Department of Health and Human Services to establish the Task Force on Research Specific to Pregnant Women and Lactating Women to report on issues including: (1) the development of safe and effective therapies for such women, (2) ethical issues surrounding the inclusion of such women in clinical research, and (3) federal research activities regarding such women.

The Food and Drug Administration must report specified information including the number of new drugs approved based on research that included such women in clinical trials.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Safe Medications for Moms and Babies Act of 2016

Latest action (May 13, 2016): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: May 12, 2016

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.